setoperone has been researched along with Schizophrenia in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (15.38) | 18.7374 |
1990's | 6 (46.15) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kapur, S; Mamo, D; Mann, S; Papatheodorou, G; Remington, G; Shammi, CM; Therrien, F | 1 |
Ansari, MS; Dawant, B; Jayathilake, K; Kessler, RM; Li, R; Meltzer, HY; Riccardi, P | 1 |
Graff, A; Kapur, S; Mamo, D; Mizrahi, R; Romeyer, F; Shammi, CM | 1 |
Houle, S; Jones, C; Kapur, S; McKay, G; Remington, G; Zipursky, R | 1 |
Attar-Levy, D; Martinot, JL; Monnet, F; Paillère-Martinot, ML; Recassens, C; Trichard, C | 1 |
Attar-Levy, D; Blin, J; Feline, A; Martinot, JL; Paillère-Martinot, ML; Trichard, C | 1 |
DaSilva, J; Houle, S; Jones, C; Kapur, S; Remington, G; Wilson, AA; Zipursky, RB | 1 |
Brown, GM; DaSilva, J; Houle, S; Jones, C; Kapur, S; Lewis, R; Wilson, AA; Zipursky, RB | 1 |
Kapur, S; Remington, G; Zipursky, RB | 1 |
Liddle, PF; Ngan, ET; Ruth, TJ; Yatham, LN | 1 |
Hussey, D; Kapur, S; Kecojevic, A; Lewis, R; Meyer, JH; Tauscher, J; Verhoeff, NP; Zipursky, RB | 1 |
Gelders, YG | 1 |
Ceulemans, DL; Gelders, YG; Hoppenbrouwers, ML; Janssen, PA; Reyntjens, AJ | 1 |
5 trial(s) available for setoperone and Schizophrenia
Article | Year |
---|---|
A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.
Topics: Adult; Antipsychotic Agents; Brain; Corpus Striatum; Drug Administration Schedule; Female; Humans; Male; Piperazines; Psychotic Disorders; Pyrimidinones; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Schizophrenia; Thiazoles; Tomography, Emission-Computed | 2004 |
Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.
Topics: Adult; Antipsychotic Agents; Benzamides; Benzodiazepines; Brain Chemistry; Corpus Striatum; Dopamine Antagonists; Female; Haloperidol; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Pyrimidinones; Pyrrolidines; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D3; Schizophrenia; Serotonin Antagonists | 2005 |
Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia; Basal Ganglia Diseases; Carbon Radioisotopes; Caudate Nucleus; Cerebral Cortex; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Male; Piperazines; Positron-Emission Tomography; Psychotic Disorders; Putamen; Pyridines; Pyrimidinones; Quinolones; Raclopride; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Treatment Outcome | 2007 |
5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Carbon Radioisotopes; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Male; Olanzapine; Pirenzepine; Prolactin; Pyrimidinones; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin; Salicylamides; Schizophrenia; Tomography, Emission-Computed; Treatment Outcome | 1998 |
Thymosthenic agents, a novel approach in the treatment of schizophrenia.
Topics: Brain; Butyrophenones; Humans; Isoxazoles; Piperidines; Pyrimidinones; Randomized Controlled Trials as Topic; Receptors, Serotonin; Risperidone; Ritanserin; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists | 1989 |
8 other study(ies) available for setoperone and Schizophrenia
Article | Year |
---|---|
PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.
Topics: Adult; Cerebellum; Corpus Striatum; Dopamine Antagonists; Female; Fluorine Radioisotopes; Humans; Loxapine; Male; Pyrimidinones; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin; Salicylamides; Schizophrenia; Tomography, Emission-Computed | 1997 |
Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients.
Topics: Adolescent; Adult; Amisulpride; Animals; Antipsychotic Agents; Cerebral Cortex; Chlorpromazine; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Male; Pyrimidinones; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Schizophrenia; Sulpiride; Tomography, Emission-Computed | 1998 |
No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET.
Topics: Adult; Cell Count; Cerebral Cortex; Female; Functional Laterality; Humans; Male; Pyrimidinones; Receptors, Serotonin; Schizophrenia; Tomography, Emission-Computed | 1998 |
Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects.
Topics: Antipsychotic Agents; Brain Chemistry; Cerebral Cortex; Contrast Media; Fluorine Radioisotopes; Humans; Prefrontal Cortex; Pyrimidinones; Receptors, Serotonin; Schizophrenia; Tomography, Emission-Computed | 1999 |
Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Carbon Radioisotopes; Clozapine; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Pyrimidinones; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Schizophrenia; Tomography, Emission-Computed | 1999 |
Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone.
Topics: Adolescent; Adult; Antipsychotic Agents; Brain; Female; Fluorine Radioisotopes; Frontal Lobe; Humans; Male; Pyrimidinones; Radionuclide Imaging; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Schizophrenia | 2000 |
A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia.
Topics: Adult; Age Factors; Analysis of Variance; Brain; Case-Control Studies; Contrast Media; Female; Fluorine Radioisotopes; Humans; Male; Psychiatric Status Rating Scales; Pyrimidinones; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Tomography, Emission-Computed | 2000 |
Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone.
Topics: Adult; Aged; Basal Ganglia Diseases; Female; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Pyrimidinones; Schizophrenia; Serotonin Antagonists | 1985 |